Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5A3O

Crystal structure of the LecB lectin from Pseudomonas aeruginosa in complex with Methyl 6-(cinnamido)-6-deoxy-alpha-D-mannopyranoside at 1.6 ansgtrom

Summary for 5A3O
Entry DOI10.2210/pdb5a3o/pdb
DescriptorFUCOSE-BINDING LECTIN PA-IIL, CALCIUM ION, methyl alpha-D-mannopyranoside, ... (6 entities in total)
Functional Keywordsglycoinhibitors, sugar binding protein
Biological sourcePSEUDOMONAS AERUGINOSA
Total number of polymer chains4
Total formula weight48766.69
Authors
Sommer, R.,Hauck, D.,Varrot, A.,Audfray, A.,Imberty, A.,Titz, A. (deposition date: 2015-06-02, release date: 2015-07-22, Last modification date: 2024-01-10)
Primary citationSommer, R.,Hauck, D.,Varrot, A.,Wagner, S.,Audfray, A.,Prestel, A.,Moleer, H.M.,Imberty, A.,Titz, A.
Cinnamide Derivatives of D-Mannose as Inhibitors of the Bacterial Virulence Factor Lecb from Pseudomonas Aeruginosa
Chemistryopen, 4:756-, 2015
Cited by
PubMed Abstract: Pseudomonas aeruginosa is an opportunistic Gram-negative pathogen with high antibiotic resistance. Its lectin LecB was identified as a virulence factor and is relevant in bacterial adhesion and biofilm formation. Inhibition of LecB with carbohydrate-based ligands results in a decrease in toxicity and biofilm formation. We recently discovered two classes of potent drug-like glycomimetic inhibitors, that is, sulfonamides and cinnamides of d-mannose. Here, we describe the chemical synthesis and biochemical evaluation of more than 20 derivatives with increased potency compared to the unsubstituted cinnamide. The structure-activity relationship (SAR) obtained and the extended biophysical characterization allowed the experimental determination of the binding mode of these cinnamides with LecB. The established surface binding mode now allows future rational structure-based drug design. Importantly, all glycomimetics tested showed extended receptor residence times with half-lives in the 5-20 min range, a prerequisite for therapeutic application. Thus, the glycomimetics described here provide an excellent basis for future development of anti-infectives against this multidrug-resistant pathogen.
PubMed: 27308201
DOI: 10.1002/OPEN.201500162
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.6 Å)
Structure validation

244349

数据于2025-11-05公开中

PDB statisticsPDBj update infoContact PDBjnumon